These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7522939)

  • 101. Screening for prostate cancer: an analysis of the early experience.
    Slawin KM; Ohori M; Dillioglugil O; Scardino PT
    CA Cancer J Clin; 1995; 45(3):134-47. PubMed ID: 7538042
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Efficacy of Repeated Transrectal Prostate Biopsy in Men Younger Than 50 Years With an Elevated Prostate-Specific Antigen Concentration (>3.0 ng/mL): Risks and Benefits Based on Biopsy Results and Follow-up Status.
    Park HG; Ko OS; Kim YG; Park JK
    Korean J Urol; 2014 Apr; 55(4):249-53. PubMed ID: 24741413
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer.
    Kubricht WS; Kattan MW; Sartor O; Eastham JA
    Urology; 1999 Mar; 53(3):553-6. PubMed ID: 10096383
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [The prostate cancer precision screening program: a preliminary report after recruitment of 2 159 men].
    Gu CY; Qin XJ; Huang YQ; Zhu Y; Dai B; Ye DW
    Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(42):3292-3297. PubMed ID: 31715663
    [No Abstract]   [Full Text] [Related]  

  • 105. Age-specific prostate-specific antigen: a reassessment.
    Etzioni R; Shen Y; Petteway JC; Brawer MK
    Prostate Suppl; 1996; 7():70-7. PubMed ID: 8950367
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI?
    Chang CM; McIntosh AG; Shapiro DD; Davis JW; Ward JF; Gregg JR
    BJUI Compass; 2021 May; 2(3):188-193. PubMed ID: 35475129
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Not all patients pursue prostate biopsy after abnormal prostate specific antigen results.
    Krongrad A; Kim CO; Burke MA; Granville LJ
    Urol Oncol; 1996; 2(1):35-9. PubMed ID: 21224133
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Detection rate of prostate cancer following 12-core extended biopsy in a Semi-urban Nigerian Tertiary Hospital.
    Ogbetere FE; Irekpita E
    Urol Ann; 2021; 13(2):150-155. PubMed ID: 34194141
    [TBL] [Abstract][Full Text] [Related]  

  • 109. The 4Kscore® Test Reduces Prostate Biopsy Rates in Community and Academic Urology Practices.
    Konety B; Zappala SM; Parekh DJ; Osterhout D; Schock J; Chudler RM; Oldford GM; Kernen KM; Hafron J
    Rev Urol; 2015; 17(4):231-40. PubMed ID: 26839521
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Knowledge, attitudes and experience associated with testing for prostate cancer: a comparison between male doctors and men in the community.
    Livingston P; Cohen P; Frydenberg M; Borland R; Reading D; Clarke V; Hill D
    Intern Med J; 2002; 32(5-6):215-23. PubMed ID: 12036219
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population.
    Ganpule AP; Desai MR; Manohar T; Bapat S
    Indian J Urol; 2007 Apr; 23(2):122-5. PubMed ID: 19675786
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Community-based free prostate cancer screening program.
    Jandorf L; Chang MS; Smith K; Florio A; Hall SJ
    Prog Community Health Partnersh; 2007; 1(3):215-20. PubMed ID: 19129926
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Prostate Cancer Detected by Screening in a Semi Urban Community in Southeast Nigeria: Correlations and Associations between Anthropometric Measurements and Prostate-specific Antigen.
    Ugwumba FO; Okoh AD; Echetabu KN; Udeh EI; Nnabugwu II
    Niger J Surg; 2017; 23(1):33-36. PubMed ID: 28584509
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Perceived benefits: a predictor of participation in prostate cancer screening.
    Tingen MS; Weinrich SP; Heydt DD; Boyd MD; Weinrich MC
    Cancer Nurs; 1998 Oct; 21(5):349-57. PubMed ID: 9775485
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Prostate mechanical imaging: a new method for prostate assessment.
    Weiss RE; Egorov V; Ayrapetyan S; Sarvazyan N; Sarvazyan A
    Urology; 2008 Mar; 71(3):425-9. PubMed ID: 18342178
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Barriers to planning and conducting a screening: prostate cancer.
    McDougall GJ; Adams ML; Voelmeck WF
    Geriatr Nurs; 2004; 25(6):336-40. PubMed ID: 15592249
    [TBL] [Abstract][Full Text] [Related]  

  • 117. What is the role of digital rectal examination in men undergoing serial screening of serum PSA levels?
    Loeb S; Catalona WJ
    Nat Clin Pract Urol; 2009 Feb; 6(2):68-9. PubMed ID: 19139742
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Tissue expression of MMP-9, TIMP-1, RECK, and miR338-3p in prostate gland: can it predict cancer?
    de Moraes RP; Pimenta R; Mori FNC; Dos Santos GA; Viana NI; Guimarães VR; de Camargo JA; Leite KRM; Srougi M; Nahas WC; Reis ST
    Mol Biol Res Commun; 2021 Dec; 10(4):149-156. PubMed ID: 35097136
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Public awareness and knowledge of prostate cancer in Japan: results of a survey at short-stay examination facilities.
    Egawa S; Suyama K; Shitara T; Uchida T; Koshiba K
    Int J Urol; 1998 Mar; 5(2):146-51. PubMed ID: 9559840
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.